Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Integrative Biology

Physiologic and genetic evidence links hemopexin to triglycerides in mice and humans

Abstract

Background/objectives:

Elevated triglycerides predict insulin resistance and vascular disease in obesity, but how the inert triglyceride molecule is related to development of metabolic disease is unknown. To pursue novel potential mediators of triglyceride-associated metabolic disease, we used a forward genetics approach involving inbred mice and translated our findings to human subjects.

Subjects/methods:

Hemopexin (HPX) was identified as a differentially expressed gene within a quantitative trait locus associated with serum triglycerides in an F16 advanced intercross between the LG/J and SM/J strains of mice. Hpx expression was evaluated in both the reproductive fat pads and livers of mice representing three strains, LG/J (n=25), SM/J (n=27) and C57Bl/6J (n=19), on high- and low-fat diets. The effect of altered Hpx expression on adipogenesis was studied in 3T3-L1 cells. Circulating HPX protein along with HPX expression were characterized in subcutaneous white adipose tissue samples obtained from a cohort of metabolically abnormal (n=18) and of metabolically normal (n=24) obese human subjects. We further examined the relationship between HPX and triglycerides in human atherosclerotic plaques (n=18).

Results:

HPX expression in mouse adipose tissue, but not in liver, was regulated by dietary fat regardless of genetic background. HPX increased in concert with adipogenesis in 3T3-L1 cells, and disruption of its expression impaired adipocyte differentiation. RNAseq data from the adipose tissue of obese humans showed differential expression of HPX based on metabolic disease status (P<0.05), and circulating HPX levels were correlated with serum triglycerides in these subjects (r=0.33; P=0.03). HPX was also found in an unbiased proteomic screen of human atherosclerotic plaques and shown to display differential abundance based on the extent of disease and triglyceride content (P<0.05).

Conclusions:

Our findings suggest that HPX is associated with triglycerides and provide a framework for understanding mechanisms underlying lipid metabolism and metabolic disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 2016; 133: e38–e360.

    PubMed  Google Scholar 

  2. Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, Clark JM et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007; 30: 1374–1383.

    Article  Google Scholar 

  3. Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG . Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA 2008; 300: 2142–2152.

    Article  CAS  Google Scholar 

  4. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A . Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007; 298: 299–308.

    Article  CAS  Google Scholar 

  5. Paoli M, Anderson BF, Baker HM, Morgan WT, Smith A, Baker EN . Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two beta-propeller domains. Nat Struct Biol 1999; 6: 926–931.

    Article  CAS  Google Scholar 

  6. Stohs SJ, Bagchi D . Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 1995; 18: 321–336.

    Article  CAS  Google Scholar 

  7. Tolosano E, Altruda F . Hemopexin: structure, function, and regulation. DNA Cell Biol 2002; 21: 297–306.

    Article  CAS  Google Scholar 

  8. Morgan WT, Smith A. Binding and transport of iron-porphyrins by hemopexin. In: Sykes AG (ed). Advances in Inorganic Chemistry vol. 51. Academic Press: San Diego, CA, USA, 2001.

    Google Scholar 

  9. Lin T, Sammy F, Yang H, Thundivalappil S, Hellman J, Tracey KJ et al. Identification of hemopexin as an anti-inflammatory factor that inhibits synergy of hemoglobin with HMGB1 in sterile and infectious inflammation. J Immunol 2012; 189: 2017–2022.

    Article  CAS  Google Scholar 

  10. Smith A, Morgan WT . Hemopexin-mediated heme uptake by liver. Characterization of the interaction of heme-hemopexin with isolated rabbit liver plasma membranes. J Biol Chem 1984; 259: 12049–12053.

    CAS  PubMed  Google Scholar 

  11. Baumann H, Jahreis GP, Gaines KC . Synthesis and regulation of acute phase plasma proteins in primary cultures of mouse hepatocytes. J Cell Biol 1983; 97: 866–876.

    Article  CAS  Google Scholar 

  12. Li RC, Saleem S, Zhen G, Cao W, Zhuang H, Lee J et al. Heme-hemopexin complex attenuates neuronal cell death and stroke damage. J Cereb Blood Flow Metab 2009; 29: 953–964.

    Article  CAS  Google Scholar 

  13. Hunt RC, Hunt DM, Gaur N, Smith A . Hemopexin in the human retina: protection of the retina against heme-mediated toxicity. J Cell Physiol 1996; 168: 71–80.

    Article  CAS  Google Scholar 

  14. Swerts JP, Soula C, Sagot Y, Guinaudy MJ, Guillemot JC, Ferrara P et al. Hemopexin is synthesized in peripheral nerves but not in central nervous system and accumulates after axotomy. J Biol Chem 1992; 267: 10596–10600.

    CAS  PubMed  Google Scholar 

  15. Watanabe J, Grijalva V, Hama S, Barbour K, Berger FG, Navab M et al. Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein. J Biol Chem 2009; 284: 18292–18301.

    Article  CAS  Google Scholar 

  16. Fabbrini E, Yoshino J, Yoshino M, Magkos F, Tiemann Luecking C, Samovski D et al. Metabolically normal obese people are protected from adverse effects following weight gain. J Clin Invest 2015; 125: 787–795.

    Article  Google Scholar 

  17. Robinson MD, McCarthy DJ, Smyth GK . edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010; 26: 139–140.

    Article  CAS  Google Scholar 

  18. Lawson HA, Zelle KM, Fawcett GL, Wang B, Pletscher LS, Maxwell TJ et al. Genetic, epigenetic, and gene-by-diet interaction effects underlie variation in serum lipids in a LG/JxSM/J murine model. J Lipid Res 2010; 51: 2976–2984.

    Article  CAS  Google Scholar 

  19. Lawson HA, Cady JE, Partridge C, Wolf JB, Semenkovich CF, Cheverud JM . Genetic effects at pleiotropic loci are context-dependent with consequences for the maintenance of genetic variation in populations. PLoS Genet 2011; 7: e1002256.

    Article  CAS  Google Scholar 

  20. Partridge CG, Fawcett GL, Wang B, Semenkovich CF, Cheverud JM . The effect of dietary fat intake on hepatic gene expression in LG/J AND SM/J mice. BMC Genomics 2014; 15: 99.

    Article  Google Scholar 

  21. Chen X, Cushman SW, Pannell LK, Hess S . Quantitative proteomic analysis of the secretory proteins from rat adipose cells using a 2D liquid chromatography-MS/MS approach. J Proteome Res 2005; 4: 570–577.

    Article  CAS  Google Scholar 

  22. Moreno-Navarrete JM, Ortega F, Moreno M, Ricart W, Fernandez-Real JM . Fine-tuned iron availability is essential to achieve optimal adipocyte differentiation and mitochondrial biogenesis. Diabetologia 2014; 57: 1957–1967.

    Article  CAS  Google Scholar 

  23. Lawson HA. Animal models of metabolic syndrome. In: Conn M (ed). Animal Models for the Study of Human Disease. Elsevier: Cambridge, UK, 2013; pp 243–264.

    Chapter  Google Scholar 

  24. Chen Z, Ichetovkin M, Kurtz M, Zycband E, Kawka D, Woods J et al. Cholesterol in human atherosclerotic plaque is a marker for underlying disease state and plaque vulnerability. Lipids Health Dis 2010; 9: 61.

    Article  CAS  Google Scholar 

  25. Cohen E, Aviram M, Khatib S, Rabin A, Mannheim D, Karmeli R et al. Increased levels of human carotid lesion linoleic acid hydroperoxide in symptomatic and asymptomatic patients is inversely correlated with serum HDL and paraoxonase 1 activity. J Lipids 2012; 2012: 762560.

    Article  Google Scholar 

  26. Mas S, Touboul D, Brunelle A, Aragoncillo P, Egido J, Laprevote O et al. Lipid cartography of atherosclerotic plaque by cluster-TOF-SIMS imaging. Analyst 2007; 132: 24–26.

    Article  CAS  Google Scholar 

  27. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G . Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003; 139: 802–809.

    Article  Google Scholar 

  28. Nikolskiy I, Conrad DF, Chun S, Fay JC, Cheverud JM, Lawson HA . Using whole-genome sequences of the LG/J and SM/J inbred mouse strains to prioritize quantitative trait genes and nucleotides. BMC Genomics 2015; 16: 415.

    Article  Google Scholar 

  29. Srivastava AK, Mohan S, Masinde GL, Yu H, Baylink DJ . Identification of quantitative trait loci that regulate obesity and serum lipid levels in MRL/MpJ x SJL/J inbred mice. J Lipid Res 2006; 47: 123–133.

    Article  CAS  Google Scholar 

  30. Seidelmann SB, De Luca C, Leibel RL, Breslow JL, Tall AR, Welch CL . Quantitative trait locus mapping of genetic modifiers of metabolic syndrome and atherosclerosis in low-density lipoprotein receptor-deficient mice: identification of a locus for metabolic syndrome and increased atherosclerosis on chromosome 4. Arterioscler Thromb Vasc Biol 2005; 25: 204–210.

    Article  CAS  Google Scholar 

  31. Gebre-Medhin M, Ewald U, Tuvemo T . Reduced serum proteins in diabetic children on a twice-daily insulin schedule. Acta Paediatr Scand 1985; 74: 961–965.

    Article  CAS  Google Scholar 

  32. Gabrielsen JS, Gao Y, Simcox JA, Huang J, Thorup D, Jones D et al. Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest 2012; 122: 3529–3540.

    Article  CAS  Google Scholar 

  33. Jeney V, Balla G, Balla J . Red blood cell, hemoglobin and heme in the progression of atherosclerosis. Front Physiol 2014; 5: 1–11.

    Article  Google Scholar 

  34. Mehta NU, Grijalva V, Hama S, Wagner A, Navab M, Fogelman AM et al. Apolipoprotein E-/- mice lacking hemopexin develop increased atherosclerosis via mechanisms that include oxidatice stress and altered macrophage function. Arterioscler Thromb Vasc Biol 2016; 36: 1152–1163.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr Irfan Lodhi for sharing his 3T3-L1 differentiation protocol and Dr Larry Spears for his assistance in trouble shooting the western blotting experiments. This work was supported by NIH-NIDDK K01 DK95003 and P30 DK56341 to HAL and in part by the EA annual grant contest (2012) co-sponsored by Illumina and Golden Helix to L-LG, SK and HAL. The content of this paper is solely the responsibility of the authors.

Author contributions

HAL designed the study, conducted experiments, analyzed data, wrote the manuscript and secured funding and collaborations. MZ performed the carotid endarterectomy operations, prepared the carotid artery plaque homogenates, conducted the pilot proteomics scan and assisted with manuscript preparation. JPW conducted experiments and assisted with manuscript preparation. EF collected and prepared MNO/MAO subject data. L-LG prepared the MNO/MAO RNA samples. SK provided MNO/MAO subject data and samples and assisted with manuscript preparation. CFS assisted in study design, contributed reagents, provided laboratory space and equipment for experiments and assisted in manuscript preparation.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to H A Lawson or C F Semenkovich.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on International Journal of Obesity website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lawson, H., Zayed, M., Wayhart, J. et al. Physiologic and genetic evidence links hemopexin to triglycerides in mice and humans. Int J Obes 41, 631–638 (2017). https://doi.org/10.1038/ijo.2017.19

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2017.19

This article is cited by

Search

Quick links